Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of EUR 112.43 billion. The enterprise value is 152.71 billion.

Market Cap	112.43B
Enterprise Value	152.71B

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 15.45.

PE Ratio	15.45
Forward PE	n/a
PS Ratio	1.95
PB Ratio	1.34
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.97, with an EV/FCF ratio of 14.74.

EV / Earnings	20.98
EV / Sales	2.75
EV / EBITDA	6.97
EV / EBIT	10.34
EV / FCF	14.74

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.69.

Current Ratio	1.26
Quick Ratio	0.88
Debt / Equity	0.69
Debt / EBITDA	2.55
Debt / FCF	5.56
Interest Coverage	5.57

Financial Efficiency

Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.52%.

Return on Equity (ROE)	8.62%
Return on Assets (ROA)	4.79%
Return on Invested Capital (ROIC)	6.52%
Return on Capital Employed (ROCE)	9.58%
Revenue Per Employee	711,935
Profits Per Employee	89,847
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.86%
50-Day Moving Average	22.22
200-Day Moving Average	24.89
Relative Strength Index (RSI)	38.57
Average Volume (20 Days)	8,893

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.04

Income Statement

In the last 12 months, Pfizer had revenue of EUR 57.67 billion and earned 7.28 billion in profits. Earnings per share was 1.28.

Revenue	57.67B
Gross Profit	42.92B
Operating Income	15.18B
Pretax Income	6.82B
Net Income	7.28B
EBITDA	21.53B
EBIT	15.18B
Earnings Per Share (EPS)	1.28

Full Income Statement

Balance Sheet

The company has 15.99 billion in cash and 57.60 billion in debt, giving a net cash position of -41.62 billion.

Cash & Cash Equivalents	15.99B
Total Debt	57.60B
Net Cash	-41.62B
Net Cash Per Share	n/a
Equity (Book Value)	83.68B
Book Value Per Share	14.67
Working Capital	8.69B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.91 billion and capital expenditures -2.56 billion, giving a free cash flow of 10.36 billion.

Operating Cash Flow	12.91B
Capital Expenditures	-2.56B
Free Cash Flow	10.36B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.42%, with operating and profit margins of 26.33% and 12.62%.

Gross Margin	74.42%
Operating Margin	26.33%
Pretax Margin	11.82%
Profit Margin	12.62%
EBITDA Margin	37.34%
EBIT Margin	26.33%
FCF Margin	17.96%

Dividends & Yields

This stock pays an annual dividend of 1.57, which amounts to a dividend yield of 7.83%.

Dividend Per Share	1.57
Dividend Yield	7.83%
Dividend Growth (YoY)	2.66%
Years of Dividend Growth	1
Payout Ratio	121.49%
Buyback Yield	-0.97%
Shareholder Yield	6.86%
Earnings Yield	6.47%
FCF Yield	9.21%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.22. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	n/a